Hoffmann-la Roche Inc.

Raymond Lau

Frederick Arthur Brookfield

Edward Andrew Boyd

Jonathan Gridley

Wolfgang Von Der Saal

Ulrike Reiff

Georg Tiefenthaler

Manfred Kubbies

Timothy Woodcock

Stefan Scheiblich

Matthias Koerner

Konrad Honold

Thomas Von Hirschheydt

Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer. 

Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents

The present invention relates to compounds of formula I wherein R, Rand Rare defined herein, their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.

Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents

The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.

Styrylsulfonamides

Growing community of inventors

Bracknell, United Kingdom

Raymond Lau